Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.

Morris G, Berk M.

BMC Med. 2015 Apr 1;13:68. doi: 10.1186/s12916-015-0310-y.

2.

Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.

de Sousa RT, Machado-Vieira R, Zarate CA Jr, Manji HK.

Expert Opin Ther Targets. 2014 Oct;18(10):1131-47. doi: 10.1517/14728222.2014.940893. Epub 2014 Jul 24. Review.

3.

Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care.

Sajatovic M, Forester BP, Gildengers A, Mulsant BH.

Neuropsychiatry (London). 2013 Dec 1;3(6):621-633.

4.

Oxidative stress in older patients with bipolar disorder.

Andreazza AC, Gildengers A, Rajji TK, Zuzarte PM, Mulsant BH, Young LT.

Am J Geriatr Psychiatry. 2015 Mar;23(3):314-9. doi: 10.1016/j.jagp.2014.05.008. Epub 2014 May 28.

PMID:
24974141
5.

Oxidative stress and psychological disorders.

Salim S.

Curr Neuropharmacol. 2014 Mar;12(2):140-7. doi: 10.2174/1570159X11666131120230309.

6.

Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia.

Kim HK, Andreazza AC, Yeung PY, Isaacs-Trepanier C, Young LT.

J Psychiatry Neurosci. 2014 Jul;39(4):276-85.

7.

Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

de Sousa RT, Zarate CA Jr, Zanetti MV, Costa AC, Talib LL, Gattaz WF, Machado-Vieira R.

J Psychiatr Res. 2014 Mar;50:36-41. doi: 10.1016/j.jpsychires.2013.11.011. Epub 2013 Dec 6.

8.

Stage managing bipolar disorder.

Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A, Moylan S, Malhi GS.

Bipolar Disord. 2014 Aug;16(5):471-7. doi: 10.1111/bdi.12099. Epub 2013 Jun 20. Review.

9.

Metabolic changes and DNA hypomethylation in cerebellum are associated with behavioral alterations in mice exposed to trichloroethylene postnatally.

Blossom SJ, Cooney CA, Melnyk SB, Rau JL, Swearingen CJ, Wessinger WD.

Toxicol Appl Pharmacol. 2013 Jun 15;269(3):263-9. doi: 10.1016/j.taap.2013.03.025. Epub 2013 Apr 6.

10.

Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder.

Versace A, Andreazza AC, Young LT, Fournier JC, Almeida JR, Stiffler RS, Lockovich JC, Aslam HA, Pollock MH, Park H, Nimgaonkar VL, Kupfer DJ, Phillips ML.

Mol Psychiatry. 2014 Feb;19(2):200-8. doi: 10.1038/mp.2012.188. Epub 2013 Jan 29.

11.

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.

Chiu CT, Wang Z, Hunsberger JG, Chuang DM.

Pharmacol Rev. 2013 Jan 8;65(1):105-42. doi: 10.1124/pr.111.005512. Print 2013 Jan. Review.

12.

Antioxidants as potential therapeutics for neuropsychiatric disorders.

Pandya CD, Howell KR, Pillai A.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:214-23. doi: 10.1016/j.pnpbp.2012.10.017. Epub 2012 Nov 2. Review.

13.

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.

Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.

Mol Neurodegener. 2012 Apr 11;7:13. doi: 10.1186/1750-1326-7-13.

14.

The link between angiotensin II-mediated anxiety and mood disorders with NADPH oxidase-induced oxidative stress.

Liu F, Havens J, Yu Q, Wang G, Davisson RL, Pickel VM, Iadecola C.

Int J Physiol Pathophysiol Pharmacol. 2012;4(1):28-35. Epub 2012 Feb 15.

15.

Postnatal exposure to trichloroethylene alters glutathione redox homeostasis, methylation potential, and neurotrophin expression in the mouse hippocampus.

Blossom SJ, Melnyk S, Cooney CA, Gilbert KM, James SJ.

Neurotoxicology. 2012 Dec;33(6):1518-27. doi: 10.1016/j.neuro.2012.02.017. Epub 2012 Mar 7.

16.

Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism.

Melnyk S, Fuchs GJ, Schulz E, Lopez M, Kahler SG, Fussell JJ, Bellando J, Pavliv O, Rose S, Seidel L, Gaylor DW, James SJ.

J Autism Dev Disord. 2012 Mar;42(3):367-77. doi: 10.1007/s10803-011-1260-7.

17.

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Dean O, Giorlando F, Berk M.

J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk